Inside Precision Medicine January 13, 2026
Chris Anderson

A research team at the University of Michigan has developed a machine-learning-based method to create digital twins of brain tumors that can estimate real-time metabolic activity and predict how individual gliomas will respond to specific treatments. The findings, published in Cell Metabolism, details the digital twins which integrate limited patient data with principles of biology, chemistry, and physics to simulate tumor metabolism, allowing clinicians to assess whether dietary interventions or metabolic drugs are likely to be effective before they are prescribed.

“Typically, metabolic measurements during surgeries to remove tumors can’t provide a clear picture of tumor metabolism—surgeons can’t observe how metabolism varies with time, and labs are limited to studying tissues after surgery,” said senior author Deepak Nagrath, PhD, a...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Digital Health, Provider, Technology
The Medical Futurist’s 100 Digital Health And AI Companies Of 2026
Canada: Acute Care EHR & Digital Health 2026-What's Changing Now in Adoption, Implementation, Selection and Satisfaction - Black Book Research
Digital Health Solutions at CES 2026
Small island aims to implement digital health innovations
The power of sound in a virtual world

Share Article